Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 Jun... (32023R1322)
INHALT
Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 June 2023 on the European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006
- REGULATION (EU) 2023/1322 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
- of 27 June 2023
- on the European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006
- CHAPTER I
- Objectives and tasks of the Agency
- Article 1
- Establishment of the Agency
- Article 2
- Legal status and seat
- Article 3
- Definitions
- Article 4
- General task of the Agency
- Article 5
- Specific tasks
- CHAPTER II
- Monitoring
- Article 6
- Collection and dissemination of information and data
- Article 7
- Monitoring of the drugs phenomenon and sharing of best practices
- CHAPTER III
- Preparedness
- Article 8
- The exchange of information on, and the early warning system for, new psychoactive substances
- Article 9
- Initial report
- Article 10
- Risk assessment procedure and report
- Article 11
- Exclusion from risk assessment
- Article 12
- Health and security threat assessment and preparedness
- Article 13
- European drug alert system
- Article 14
- Drug precursors
- Article 15
- Network of forensic and toxicological laboratories
- CHAPTER IV
- Competence development
- Article 16
- Evidence-based interventions, best practices and awareness raising
- Article 17
- Assessment scheme for national measures
- Article 18
- Support to Member States
- Article 19
- Training
- Article 20
- International cooperation and technical assistance
- Article 21
- Research and innovation
- CHAPTER V
- Organisation of the Agency
- Article 22
- Administrative and management structure
- Article 23
- Composition of the Management Board
- Article 24
- Functions of the Management Board
- Article 25
- Chairperson of the Management Board
- Article 26
- Meetings of the Management Board
- Article 27
- Voting rules of the Management Board
- Article 28
- Executive Board
- Article 29
- Executive Director
- Article 30
- Responsibilities of the Executive Director
- Article 31
- Scientific Committee
- Article 32
- The European Information Network on Drugs and Drug Addiction
- Article 33
- National focal point
- Article 34
- Tasks of the national focal points
- Article 35
- Assessment of the national focal points
- CHAPTER VI
- Financial provisions
- Article 36
- Single programming document
- Article 37
- Budget
- Article 38
- Fees
- Article 39
- Establishment of the budget
- Article 40
- Implementation of the budget
- Article 41
- Presentation of accounts and discharge
- Article 42
- Financial rules
- CHAPTER VII
- Staff
- Article 43
- General provision
- Article 44
- Seconded national experts and other staff
- CHAPTER VIII
- General and final provisions
- Article 45
- Privileges and immunities
- Article 46
- Language arrangements
- Article 47
- Transparency
- Article 48
- Combatting fraud
- Article 49
- Protection of classified and sensitive non-classified information
- Article 50
- Liability
- Article 51
- Evaluation and review
- Article 52
- Administrative inquiries
- Article 53
- Cooperation with other organisations and bodies
- Article 54
- Cooperation with third countries
- Article 55
- Cooperation with civil society organisations
- Article 56
- Headquarters Agreement and operating conditions
- Article 57
- Legal succession
- Article 58
- Transitional arrangements concerning the Management Board
- Article 59
- Transitional arrangements concerning the Executive Director
- Article 60
- Transitional arrangements concerning the national focal points
- Article 61
- Transitional budgetary provisions
- Article 62
- Repeal of Regulation (EC) No 1920/2006
- Article 63
- Entry into force
- ANNEX
- Correlation table
Feedback